{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:43:29Z","timestamp":1777866209544,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T00:00:00Z","timestamp":1384473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["W1224"],"award-info":[{"award-number":["W1224"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["J 3232"],"award-info":[{"award-number":["J 3232"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["25092-B13"],"award-info":[{"award-number":["25092-B13"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1P01AI097092-01A1"],"award-info":[{"award-number":["1P01AI097092-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.vaccine.2013.11.036","type":"journal-article","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T23:55:49Z","timestamp":1384991749000},"page":"355-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge"],"prefix":"10.1016","volume":"32","author":[{"given":"Miriam","family":"Klausberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Palmberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Hai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy A.","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Margine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana","family":"Hirsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reingard","family":"Grabherr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.11.036_bib0005","unstructured":"WHO. Human infection with influenza A (H7N9) virus in China. WHO; n.d."},{"key":"10.1016\/j.vaccine.2013.11.036_bib0010","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0015","unstructured":"WHO. Human infection with avian influenza A (H7N9) virus \u2013 update. WHO; n.d."},{"key":"10.1016\/j.vaccine.2013.11.036_bib0020","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0140-6736(13)60938-1","article-title":"Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses","volume":"381","author":"Liu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0025","unstructured":"National Health and Family Planning Commission. Diagnosis and treatment guideline for human infection with influenza A (H7N9) virus, 2nd ed. Beijing NPFPC, 2013; n.d. Available from http:\/\/www.moh.gov.cn\/mohgjhzs\/s7952\/201304\/98ceede1daf74a45b1105f18c4e23ece.shtm."},{"key":"10.1016\/j.vaccine.2013.11.036_bib0030","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1038\/emi.2013.30","article-title":"Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection","volume":"2","author":"Liu","year":"2013","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0035","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(13)61125-3","article-title":"Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance","volume":"381","author":"Hu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0040","doi-asserted-by":"crossref","first-page":"12401","DOI":"10.1128\/JVI.79.19.12401-12407.2005","article-title":"Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain","volume":"79","author":"De Wit","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1750-2659.2007.00022.x","article-title":"Generation of candidate human influenza vaccine strains in cell culture \u2013 rehearsing the European response to an H7N1 pandemic threat","volume":"1","author":"Whiteley","year":"2007","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0050","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1128\/CVI.00174-07","article-title":"Development and evaluation of an influenza virus subtype H7N2 vaccine candidate for pandemic preparedness","volume":"14","author":"Pappas","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0055","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.vaccine.2008.01.036","article-title":"Development of Eurasian H7N7\/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine","volume":"26","author":"Jadhao","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0060","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1016\/j.vaccine.2009.03.082","article-title":"A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults","volume":"27","author":"Talaat","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0065","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1128\/JVI.01085-13","article-title":"Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin","volume":"87","author":"Goff","year":"2013","journal-title":"J Virol"},{"issue":"40","key":"10.1016\/j.vaccine.2013.11.036_bib0070","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/j.vaccine.2013.07.043","article-title":"Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A\/Anhui\/1\/2013 (H7N9) protection and heterologous A\/chicken\/Jalisco\/CPA1\/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus","volume":"31","author":"Smith","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0075","first-page":"1133","article-title":"Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice","volume":"171","author":"Abe","year":"2003","journal-title":"J Immunol (Baltim., MD)"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0080","doi-asserted-by":"crossref","first-page":"e51559","DOI":"10.1371\/journal.pone.0051559","article-title":"Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity","volume":"7","author":"Margine","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0085","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12033-010-9268-3","article-title":"Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines","volume":"45","author":"Krammer","year":"2010","journal-title":"Mol Biotechnol"},{"issue":"4","key":"10.1016\/j.vaccine.2013.11.036_bib0090","doi-asserted-by":"crossref","first-page":"e34226","DOI":"10.1371\/journal.pone.0034226","article-title":"SweetBac:. A new approach for the production of mammalianised glycoproteins in insect cells","volume":"7","author":"Palmberger","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0095","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1128\/JVI.73.11.9679-9682.1999","article-title":"Rescue of influenza A virus from recombinant DNA","volume":"73","author":"Fodor","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0100","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0105","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0110","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0115","doi-asserted-by":"crossref","first-page":"e43603","DOI":"10.1371\/journal.pone.0043603","article-title":"A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates","volume":"7","author":"Krammer","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0120","unstructured":"Bac-to-Bac Baculovirus Expression System, User Manual, Version F as of 04 September 2010; n.d. Available from http:\/\/tools.lifetechnologies.com\/content\/sfs\/manuals\/bactobac_man.pdf."},{"key":"10.1016\/j.vaccine.2013.11.036_bib0125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0192-0561(00)00033-3","article-title":"In vivo acute depletion of CD8(+) T cells before murine cytomegalovirus infection upregulated innate antiviral activity of natural killer cells","volume":"22","author":"Salem","year":"2000","journal-title":"Int J Immunopharmacol"},{"issue":"5","key":"10.1016\/j.vaccine.2013.11.036_bib0130","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.4049\/jimmunol.1300954","article-title":"Protective CD8T cell-mediated immunityagainst influenza A virus infection following influenza virus-like particle vac-cination","volume":"191","author":"Hemann","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0135","first-page":"939860","article-title":"Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines","volume":"2011","author":"Hillaire","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0140","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1128\/JVI.00970-07","article-title":"Evaluation of replication and pathogenicity of avian influenza A H7 subtype viruses in a mouse model","volume":"81","author":"Joseph","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0145","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/jama.2013.6589","article-title":"Major challenges in providing an effective and timely pandemic vaccine for influenza A (H7N9)","volume":"309","author":"Osterholm","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(13)61171-X","article-title":"Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases","volume":"382","author":"Cowling","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0155","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.procbio.2011.02.019","article-title":"Production of immunogenic one-component avian H7-subtype influenza virus-like particles","volume":"46","author":"Chang","year":"2011","journal-title":"Process Biochem"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.virol.2008.05.021","article-title":"A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets","volume":"378","author":"Joseph","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0165","unstructured":"WHO. Clinical evaluation of influenza vaccines. WHO; n.d."},{"key":"10.1016\/j.vaccine.2013.11.036_bib0170","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.vaccine.2009.01.116","article-title":"A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine","volume":"27","author":"Cox","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0175","doi-asserted-by":"crossref","first-page":"e49704","DOI":"10.1371\/journal.pone.0049704","article-title":"A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine","volume":"7","author":"Couch","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0180","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.vaccine.2012.10.111","article-title":"Global production capacity of seasonal influenza vaccine in 2011","volume":"31","author":"Partridge","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0185","unstructured":"Report of the second WHO Consultation on the Global Action Plan for Influenza Vaccines (GAP), Geneva, Switzerland, 12\u201314 July 2011; n.d. Availble from http:\/\/whqlibdoc.who.int\/publications\/2012\/9789241564410_eng.pdf."},{"issue":"4","key":"10.1016\/j.vaccine.2013.11.036_bib0190","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.coviro.2013.05.001","article-title":"Role of T cell immunity in recovery from influenza virusinfection","volume":"3","author":"Sun","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0195","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1084\/jem.175.4.1143","article-title":"Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge","volume":"175","author":"Bender","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0200","first-page":"171","article-title":"The role of the antibody response in influenza virus infection","volume":"260","author":"Gerhard","year":"2001","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0205","first-page":"118","article-title":"Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes","volume":"32","author":"Cubas","year":"2009","journal-title":"J Immunother (Hagerstown, MD)"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0210","doi-asserted-by":"crossref","first-page":"e71534","DOI":"10.1371\/journal.pone.0071534","article-title":"Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice","volume":"8","author":"Muramatsu","year":"2013","journal-title":"PLoS ONE"},{"issue":"19","key":"10.1016\/j.vaccine.2013.11.036_bib0215","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglu-tinin stalk-based universal vaccine constructs protect against group 2 influenzaA viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0220","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1016\/j.vaccine.2011.07.064","article-title":"H7 avian influenza virus vaccines protect chickens against challenge with antigenically diverse isolates","volume":"29","author":"Abbas","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0225","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1586\/erv.09.2","article-title":"Baculovirus vector as a delivery vehicle for influenza vaccines","volume":"8","author":"He","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0230","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1021\/pr200086v","article-title":"Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity","volume":"10","author":"Song","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.vaccine.2013.11.036_bib0235","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1743-422X-10-141","article-title":"Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches","volume":"10","author":"Thompson","year":"2013","journal-title":"Virol J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13015533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13015533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:13:08Z","timestamp":1777536788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13015533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0264410X13015533"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}